SERMORELIN (GRF 1-29) 5mg
SERMORELIN (GRF 1-29) 5mg
Each VIAL contains 5mg
Sermorelin (GRF 1-29) is a Growth Hormone Releasing Hormone that stimulates the brain to release GH from the pituitary gland. It is often used as an anti-aging therapy agent. Sermorelin contains 29 amino acids (GRF 1-29) in contrast to HGH which contains all 191 amino acids.
Security policy (edit with Customer reassurance module)
Delivery policy (edit with Customer reassurance module)
Return policy (edit with Customer reassurance module)
SERMORELIN, also known as GRF 1-29, is a Growth Hormone Releasing Hormone produced by the brain that stimulates the production and release of Growth Hormone.
SERMORELIN was first developed in the 70s, which is thought to be the shortest fully functional fragment of GHRH and has been used as a test for Growth Hormone secretion. It is often used extensively in Anti-aging Therapy along with Testosterone in men. Sermorelin Acetate is a growth hormone secretagogue, which means that it stimulates the pituitary gland to produce and secrete growth hormone. Also, SERMORELIN and Modified GRF (1-29) contains 29 amino acids whereas HGH is a larger molecule containing 191 amino acids.
The Sermorelin Acetate Peptide and HGH
SERMORELIN , which shares similar structure to CJC-1295 (modified GRF (1-29)), is a bio-identical synthetic hormone that is extremely effective in increasing the amount of HGH. Human Growth Hormone is a hormone released by the body that controls the reproduction and growth of the cells and each of the organs in the body. At a young age, the body's HGH production is most active while the growth rate is at its highest point. After the age of 30, for every decade of life, there is a 14% reduction in HGH production . By the age of 40, HGH production is about 40 percent of what it was at the age of 20. With the further development of Growth Hormone Releasing Factors (GHRF), such as Modified GRF 1-29, HGH production may possibly begin again by stimulating the pituitary gland.
Sermorelin and Research
Since 1980, scientists have been studying GHRH (growth hormone releasing hormones).
Dr. D. Rudman was testing SERMORELIN as a tool for anti-aging processes and Dr. William Wehrenberg was looking at different peptides and particularly GHRH to identify which part of it is needed for pituitary gland stimulating response. His results after eliminating single amino acids showed that 29 amino-acid-chains were held responsible for pituitary stimulation. Many research studies have concluded that SERMORELIN is a well tolerated analogue of GHRH. As a result, this is suitable for use as a provocative test of growth hormone deficiency (Prakash and Goa 1999). In 1999, both researchers, Goa and Prakash checked Sermorelin Growth Hormone as provocative testing method for deficiency of endogenous Growth hormone. SERMORELIN therapy increased the volume of hormone secreted by the stimulated pituitary gland, which is later converted by the liver into IGF-1. The increased amount of IGF-1 in the blood stream leads to many benefits from the use of Sermorelin: increasing metabolism and growth of new cells within the body’s organs and bones.
SERMORELIN use has the following benefits:
Anti – aging